These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3136544)

  • 1. Treatment of occupational lead poisoning by slow subcutaneous administration of CaNa2 EDTA.
    Cicchella G; Arcangeli G; Rizzardini L
    Sci Total Environ; 1988 Jun; 71(3):551-2. PubMed ID: 3136544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with oral and parenteral use of CaNa2 EDTA].
    Vasiljević S; Filipović DK; Andjelovski A
    Arh Hig Rada Toksikol; 1969; 20(4):679-86. PubMed ID: 4992050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of zinc in urine at the use of CaNa2 EDTA in workers exposed to lead].
    Durić D; Bojović V; Graovac-Leposavić L; Milić S
    Arh Hig Rada Toksikol; 1969; 20(4):687-91. PubMed ID: 4992051
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the fate in the body of calcium disodium salt of ethylenediaminotetraacetic acid (CaNa2 EDTA) at different ways of its administration].
    Ashbel' SI; Khil' RG; Shatrova SP
    Farmakol Toksikol; 1966; 29(2):235-7. PubMed ID: 4970459
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the treatment of occupational saturnism with CaNa2 EDTA aerosols].
    Ashbel' SI; Khil' RG; Shatrova SP
    Gig Tr Prof Zabol; 1965 Mar; 9(3):24-8. PubMed ID: 4958364
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lead in cerebrospinal fluid before and after therapy with CaNa2 EDTA].
    Prpić-Majić D; Vurdelja B; Beritić T
    Arh Hig Rada Toksikol; 1969; 20(4):645-50. PubMed ID: 4992047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Personal experiences in the treatment of lead poisoning with chelating agents].
    Prpić-Majić D; Sarić M; Vurdelja B; Beritić T; Markićević A; Kersang E
    Arh Hig Rada Toksikol; 1969; 20(4):665-77. PubMed ID: 4992049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of lead poisoning. Comparison between the effect of sodium calcium EDTA and penicillamine used orally and intravenously].
    Selander S
    Arh Hig Rada Toksikol; 1969; 20(4):657. PubMed ID: 4992048
    [No Abstract]   [Full Text] [Related]  

  • 9. EDTA plus zinc as therapy of lead intoxication: preliminary results.
    Boscolo P; Porcelli G; Menini E; Finelli VN
    Med Lav; 1983; 74(5):370-5. PubMed ID: 6420654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of oral and intravenous tests using calcium-EDTA to measure lead deposits in the body].
    Sánchez Sánchez ML; Arroyo Vicente M; Elías Arcalís A; Rubio Pérez P
    Rev Clin Esp; 1983 May; 169(4):241-4. PubMed ID: 6414057
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of lead levels in an exposed population. I: analytical criteria and treatment].
    Sánchez Sánchez ML; Arroyo Vicente M; Calvo Manuel E; Millan Núñez-Cortés J; Espinos Pérez D; Rubio Pérez P
    Rev Clin Esp; 1980 Apr; 157(1):35-8. PubMed ID: 6771837
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the CaNa2 EDTA Pb-mobilization test to detect occult lead nephropathy.
    Wedeen RP
    Uremia Invest; 1985-1986; 9(2):127-30. PubMed ID: 3939486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead intoxication in industry.
    Galton-Fenzi D
    Med J Aust; 1987 Jan; 146(2):113. PubMed ID: 3099140
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the diminution rates of lead in blood and lead mobilized by CaEDTA after termination of occupational exposure: a long-term observation in two lead workers.
    Araki S; Murata K; Aono H; Yanagihara S; Ushio K
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):475-86. PubMed ID: 6422049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
    Strickland GT; Hwang YF; Chang NK; Blackwell RQ
    Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):569-74. PubMed ID: 828980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of lead and zinc in plasma, erythrocytes, and urine and ALAD in erythrocytes following intravenous infusion of CaEDTA in lead workers.
    Araki S; Aono H; Fukahori M; Tabuki K
    Arch Environ Health; 1984; 39(5):363-7. PubMed ID: 6439129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occupationally-nonrelated urinary excretion of lead following administration of CaNa2-EDTA].
    Gorn LE
    Gig Tr Prof Zabol; 1970 Sep; 14(9):49-50. PubMed ID: 4991789
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropsychologic and postural sway improvement after Ca(++)-EDTA chelation for mild lead intoxication.
    Linz DH; Barrett ET; Pflaumer JE; Keith RE
    J Occup Med; 1992 Jun; 34(6):638-41. PubMed ID: 1619495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A successfully treated case of chronic lead neuropathy observed in an old professional painter].
    Hino M
    Nihon Naika Gakkai Zasshi; 1985 Nov; 74(11):1535-40. PubMed ID: 3938470
    [No Abstract]   [Full Text] [Related]  

  • 20. Chelation therapy in lead nephropathy.
    Morgan JM
    South Med J; 1975 Aug; 68(8):1001-6. PubMed ID: 125923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.